Profil bibliographique

Katrin Marie Sjoquist

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

168Publications signalées

3866Citations signalées

7Affiliations récentes

Institutions déclarées

The University of Sydney Australian Research Council Cooperative Trials Group for Neuro-Oncology MRC Clinical Trials Unit at UCL St George Hospital Australia New Zealand Gynaecological Oncology Group National Health and Medical Research Council

Domaines associés

Gastric Cancer Management and OutcomesColorectal Cancer Treatments and StudiesPancreatic and Hepatic Oncology ResearchCancer Genomics and DiagnosticsFibroblast Growth Factor Research

Publications récentes

2026 articleOpenAlex

Evaluating longitudinal toxicity and adverse event in cetuximab-treated metastatic colorectal cancer: a pooled analysis from 1,302 patients in ARCAD database

Jun Yin, Katherine E. Francis, Guilherme S. Lopes, Jane So et autres

0 citationsJNCI Journal of the National Cancer Institute

Accès ouvert 2026 articleOpenAlex

Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2 EMBRACE trial

Katrin Marie Sjoquist, Alexander Dobrovic, Kristy P. Robledo, Ksenija Nesic et autres

0 citationsBritish Journal of Cancer

2026 articleOpenAlex

Time to Treatment Failure as an End Point in Pragmatic Oncology Trials: Association With Progression-Free Survival Across Randomized Studies

Janene Dalrymple, Rebecca Symons, Katrin Marie Sjoquist, Sally J. Lord et autres

0 citationsJCO Precision Oncology

Accès ouvert 2026 articleOpenAlex

[177Lu]Lu-DOTATATE PRRT and CAPTEM chemotherapy for pancreas and small bowel neuroendocrine tumours: The AGITG CONTROL NETS Multi-centre randomized trial

David L Chan, Katrin Marie Sjoquist, David Ransom, David Wyld et autres

0 citationsEuropean Journal of Cancer

Accès ouvert 2026 articleOpenAlex

Genomic Therapy Matching in Rare and Refractory Cancers

Frank P. Lin, Subotheni Thavaneswaran, John P. Grady, Christine E. Napier et autres

6 citationsJAMA Oncology

2025 articleOpenAlex

Health-related quality-of-life outcomes with regorafenib in advanced gastric and esophagogastric junction cancer: results from the INTEGRATE trials

Andrew Martin, Yu Yang Soon, Katrin Marie Sjoquist, Nick Pavlakis et autres

0 citationsGastric Cancer

Accès ouvert 2025 articleOpenAlex

Development and validation of a prognostic model incorporating patient reported outcomes for advanced gastric and esophageal carcinoma (AGOC) using individual patient data from two AGITG randomized clinical trials

Sayeda Naher, David Espinoza, Peter Grimison, Kohei Shitara et autres

1 citationGastric Cancer

Accès ouvert 2025 articleOpenAlex

LBA80 Regorafenib plus nivolumab vs investigator’s choice of chemotherapy in previously treated gastric or gastroesophageal cancer: INTEGRATE IIb, a randomized phase 3 AGITG Intergroup [NHMRC-CTC/IKF/AIO, ACCRU, TCOG/NHRI] study

David S. Goldstein, Katrin Marie Sjoquist, Daniela Morales Espinosa, Sun Young Rha et autres

4 citationsAnnals of Oncology

Accès ouvert 2025 articleOpenAlex

INTEGRATE pooled phase 2/3 results are robust to postprogression switching and the winner’s curse

Yu Yang Soon, Katrin Marie Sjoquist, Ian C. Marschner, I. Manjula Schou et autres

0 citationsJNCI Cancer Spectrum

2025 conference-abstractOpenAlex

Genomic and outcome analysis of recurrent versus de novo metastatic pancreatic ductal adenocarcinoma (PDAC) receiving systemic therapy: Results from the Australian MoST and CaSP screening programs.

Frank Lin, David Goldstein, John P. Grady, Christine E. Napier et autres

0 citationsJournal of Clinical Oncology

Accès ouvert 2025 articleOpenAlex

A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancer

Jennifer J. Knox, Mairéad G. McNamara, I. Bazin, Do‐Youn Oh et autres

13 citationsJournal of Hepatology

Accès ouvert 2025 conference-abstractOpenAlex

AGITG ASCEND: Randomised, double-blind phase II study of certepetide or placebo added to gemcitabine plus nab-paclitaxel in patients with untreated metastatic pancreatic ductal adenocarcinoma: Initial results.

Andrew Dean, Katrin Marie Sjoquist, Val Gebski, Christos S. Karapetis et autres

3 citationsJournal of Clinical Oncology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.